Ramos, Marcus F. K. P; Pereira, Marina A; Amorim, Larissa C; Mello, Evandro S. de; Faraj, Sheila F; Ribeiro Junior, Ulysses 
; Hoff, Paulo Marcelo Gehm ; Cecconello, Ivan ; Castria, Tiago B. de
Source: Journal of surgical oncology. Unidade: FM
Subjects: ADENOCARCINOMA, ANTÍGENOS, HERPES SIMPLES, ESTUDOS RETROSPECTIVOS, NEOPLASIAS GÁSTRICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Marcus F. K. P et al. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?. Journal of surgical oncology, v. 121, n. 5, p. 804-813, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25792. Acesso em: 11 nov. 2024.APA
Ramos, M. F. K. P., Pereira, M. A., Amorim, L. C., Mello, E. S. de, Faraj, S. F., Ribeiro Junior, U., et al. (2020). Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? Journal of surgical oncology, 121( 5), 804-813. doi:10.1002/jso.25792NLM
Ramos MFKP, Pereira MA, Amorim LC, Mello ES de, Faraj SF, Ribeiro Junior U, Hoff PMG, Cecconello I, Castria TB de. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 804-813.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/jso.25792Vancouver
Ramos MFKP, Pereira MA, Amorim LC, Mello ES de, Faraj SF, Ribeiro Junior U, Hoff PMG, Cecconello I, Castria TB de. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 804-813.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/jso.25792
